Yeast mutant strain HS-y010 producing high-concentration heme, and method for high heme production using same
The wild-type Saccharomyces cerevisiae mutant strain HS-Y010, produced through ultraviolet irradiation, enhances heme production, offering a non-GMO, efficient, and safe solution for heme production in alternative meat products, addressing consumer and production challenges.
Patent Information
- Application Number
- PCT/KR2024/001463
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2023-05-09
- Filing Date
- 2024-01-31
- Publication Date
- 2024-11-14
AI Technical Summary
Current methods for producing heme for alternative meat products rely on GMO yeast, which faces consumer resistance, and traditional animal-based methods are inefficient and pose safety risks, necessitating a safer and more efficient heme production method.
Development of a wild-type Saccharomyces cerevisiae mutant strain HS-Y010, created by irradiating Saccharomyces cerevisiae KCCM12638 with ultraviolet rays, which enhances heme production capabilities, allowing for a non-GMO, safer, and more efficient heme production process.
The mutant strain HS-Y010 exhibits improved heme production, enabling the production of high-quality heme for use in food compositions, such as alternative meat products, without the need for GMOs or animal-derived materials, addressing consumer concerns and production inefficiencies.
Smart Images

Figure KR2024001463_14112024_PF_FP_ABST
Abstract
Description
Yeast mutant strain HS-Y010 producing high concentrations of heme and method for high-concentration heme production using the same
[0001] The present invention relates to a yeast mutant strain HS-Y010 that produces a high concentration of heme and a method for producing heme at high concentrations using the same, and more particularly, to a Saccharomyces yeast mutant strain having improved heme production ability compared to the wild type, which is produced by irradiating wild-type Saccahromyces cerevisiae with ultraviolet rays under specific conditions, a method for producing the yeast mutant strain, a method for producing heme using the yeast mutant strain, a medium composition for culturing the yeast mutant strain, and a food composition comprising heme produced from the yeast mutant strain.
[0002] Interest in alternative protein sources is growing as a solution to issues such as global warming, food shortages, and animal welfare. Furthermore, with consumers' global health concerns and the growing number of vegetarians, interest in meat alternatives is also growing. In line with this social trend, the development and launch of various alternative meat products is actively underway, and the market for plant-based meat alternatives, which offer a health-conscious alternative to animal meat, is steadily growing.
[0003] The initial plant-based meat substitute manufacturing technology began with Textured Vegetable Protein (TVP) as the main raw material, and has developed in the following order: diversification of raw materials, research on the characteristics of each raw material, realization of meat texture using high-moisture molding technology, and production and addition of heme, a key element of meat flavor, using biotechnology.
[0004] Impossible Foods, a food tech company considered to be technologically advanced in the meat substitute market, produces and adds heme, which plays a key role in imparting flavor to meat, using GMO (genetically modified organism) yeast. The related technology is disclosed in Patent Document 1. However, consumers who oppose GMO-derived foods have a negative perception of the consumption of heme produced using GMO yeast. Meanwhile, in Korea, as in the US and Europe, interest in meat substitutes is growing, and consumption of related foods is also increasing. However, most of the raw materials for currently produced meat substitutes depend on imports, and research is needed to replace these with domestic resources. In particular, the trend of strengthening regulations on GMO-derived foods in Korea limits the addition of heme produced using GMO yeast to meat substitutes.
[0005] Meanwhile, heme is generally extracted from animal blood by organic solvents or enzymatic hydrolysis, but the safety of heme separated and purified from slaughtered blood is questionable due to the risk of diseases that can be caused in animals, such as mad cow disease, and the low content in blood requires a lot of blood. In addition, since this method necessarily requires animal slaughter, consumers pursuing a vegetarian diet do not prefer to consume meat substitutes containing heme extracted by slaughtering animals.
[0006] Saccahromyces cerevisiae is a unicellular eukaryote and a GRAS (Generally Recognized as Safe) strain that has been used for alcohol and bakery purposes in food processing for a long time. In the present invention, we sought to develop a technology that can improve the heme productivity of yeast in a simpler way using wild-type yeast. Accordingly, among various yeast strains already used in the food industry, a wild-type yeast strain with high heme productivity was selected as a parent strain, and the parent strain was irradiated with ultraviolet rays under specific conditions to produce a mutant strain with improved heme productivity compared to the wild-type strain, thereby completing the present invention.
[0007] [Prior Art Literature]
[0008] [Patent Document]
[0009] (Patent Document 1) Republic of Korea Patent No. 10-2229968
[0010] The present invention aims to provide a Saccharomyces yeast mutant strain having improved heme production ability compared to the wild type, which is produced by irradiating wild type Saccahromyces cerevisiae with ultraviolet rays under specific conditions.
[0011] Another object of the present invention is to provide a method for producing a Saccharomyces yeast mutant strain having improved heme production ability compared to the wild type, a method for producing heme using the yeast mutant strain, and a medium composition for culturing the yeast mutant strain.
[0012] Another object of the present invention is to provide a food composition comprising heme produced from the yeast mutant strain.
[0013] To solve the above-described problem, the present invention provides a Saccharomyces cerevisiae mutant strain HS-Y010 (accession number KCTC 15341BP) having improved heme production ability compared to the wild type.
[0014] In the present invention, the mutant strain HS-Y010 may be derived from Saccharomyces cerevisiae KCCM12638, a yeast strain for producing American whiskey.
[0015] In the present invention, the mutant strain HS-Y010 is irradiated with ultraviolet rays of 250 to 260 nm wavelength at a rate of 3000 to 9000 mW / cm at a position 20 to 50 cm away in the vertical direction to Saccharomyces cerevisiae KCCM12638. 2 It can be manufactured by irradiating for 1 to 2 hours with an amount of .
[0016] In the present invention, the mutant strain HS-Y010 may have single nucleotide sequence mutations of 2383T>A mutation in chromosome 1, 1783G>A mutation in chromosome 2, 570166G>T mutation in chromosome 5, 8579T>C, 158964T>A mutation in chromosome 7, 364680A>T, 526390T>A mutation in chromosome 8, 1064817G>T mutation in chromosome 12, 908390C>T mutation in chromosome 13, 783791C>T, 783810G>T mutation in chromosome 14, and 30149A>T mutation in chromosome 15.
[0017] The present invention also provides a method for producing a Saccharomyces cerevisiae mutant strain HS-Y010 (accession number KCTC 15341BP) having improved heme production ability compared to the wild type, comprising the following steps:
[0018] a) a step of pre-cultivating Saccharomyces cerevisiae KCCM12638; and
[0019] b) A step of irradiating the above-mentioned pre-cultured Saccharomyces cerevisiae KCCM12638 with ultraviolet rays.
[0020] In the present invention, the manufacturing method may additionally include, between steps a) and b), a step a') of diluting the pre-cultured strain so that the optical density at 600 nm becomes 0.5 to 1.5.
[0021] In the present invention, step b) is to irradiate Saccharomyces cerevisiae KCCM12638 with ultraviolet rays of 250 to 260 nm wavelength at a distance of 20 to 50 cm in the vertical direction at 3000 to 9000 mW / cm 2 It can be performed by investigating for 1 to 2 hours with an investigation amount of .
[0022] In the present invention, after step b), a step c) of selecting a mutant strain having a single nucleotide sequence mutation of 2383T>A mutation in chromosome 1, 1783G>A mutation in chromosome 2, 570166G>T mutation in chromosome 5, 8579T>C, 158964T>A mutation in chromosome 7, 364680A>T, 526390T>A mutation in chromosome 8, 1064817G>T mutation in chromosome 12, 908390C>T mutation in chromosome 13, 783791C>T, 783810G>T mutation in chromosome 14, and 30149A>T mutation in chromosome 15 may be additionally included compared to Saccharomyces cerevisiae KCCM12638.
[0023] In addition, the present invention provides a method for producing heme using the above-described Saccharomyces cerevisiae mutant strain HS-Y010 (accession number KCTC 15341BP).
[0024] In the present invention, the heme production method may include the following steps:
[0025] a) a step of culturing Saccharomyces cerevisiae mutant strain HS-Y010 (accession number KCTC 15341BP); and
[0026] b) A step of recovering heme from the above strain.
[0027] In the present invention, the strain of step a) can be cultured in a medium containing at least one selected from the group consisting of glucose, fructose or galactose as a carbon source, and yeast extract, peptone, tryptone, malt extract, beef extract, casein, soytone, sodium nitrate (NaNO3), ammonium chloride (NH4Cl) and ammonium sulfate ((NH4)2SO4) as a nitrogen source.
[0028] In the present invention, the nitrogen source may be 2 to 6% (w / v) of yeast extract and 0.1 to 3% (w / v) of peptone.
[0029] In the present invention, the strain of step a) can be cultured in a fed-batch manner at a pH of 3 to 6, at a stirring speed of 100 to 1500 rpm (revolutions per minute), and by injecting air at a rate of 0.5 to 10 vvm (aeration volume / medium volume / minute).
[0030] Additionally, the present invention provides a medium composition for culturing Saccharomyces cerevisiae mutant strain HS-Y010 (Accession No. KCTC 15341BP) comprising:
[0031] i) 3 to 7% (w / v) of glucose, fructose or galactose as a carbon source; and
[0032] ii) 2 to 6% (w / v) yeast extract and 0.1 to 3% (w / v) peptone as nitrogen source.
[0033] At this time, the above medium composition may be a medium for heme production.
[0034] Furthermore, the present invention provides a food composition comprising a Saccharomyces cerevisiae mutant strain HS-Y010 (accession number KCTC 15341BP) having an increased heme production ability compared to the wild type, a culture of the strain, heme produced from the strain, or heme isolated from a culture of the strain.
[0035] In the present invention, the food may be artificial meat or a meat substitute food.
[0036] In addition, the present invention provides the use of the aforementioned medium composition for increasing heme production of Saccharomyces cerevisiae mutant strain HS-Y010 (accession number KCTC 15341BP).
[0037] The Saccharomyces cerevisiae mutant strain HS-Y010 (Accession No. KCTC 15341BP) according to the present invention is produced by irradiating the wild-type Saccharomyces cerevisiae KCCM12638, which is already used in the food industry, with ultraviolet rays under specific conditions, thereby enabling the acquisition of a yeast strain exhibiting high heme production ability in a much simpler and simpler manner than existing GMO yeast. The Saccharomyces cerevisiae mutant strain HS-Y010 (Accession No. KCTC 15341BP) produced in this manner exhibits improved heme production ability compared to the wild-type, enabling more efficient heme production.
[0038] Figure 1 is a schematic diagram showing a method for extracting heme present in yeast strain cells.
[0039] Figure 2 shows the results of fed-batch culture of Saccharomyces cerevisiae KCCM12638 strain using 40YP20D (4% (w / v) yeast extract (40 g / L), 2% (w / v) bacto peptone (20 g / L), 2% (w / v) glucose (20 g / L)) medium at pH 3.5. (A) shows cell, metabolite, and heme concentrations, (B) shows dissolved oxygen (DO%), and (C) shows the feeding solution injection rate.
[0040] Figure 3 shows the results of fed-batch culture of Saccharomyces cerevisiae KCCM12638 strain using 40YP20D medium under pH 4.5 conditions. (A) shows cell, metabolite, and heme concentrations, (B) shows dissolved oxygen content (DO%), and (C) shows the feeding solution injection rate.
[0041] Figure 4 is a graph showing the survival rate of Saccharomyces cerevisiae KCCM12638 strain according to the UV irradiation time.
[0042] Figure 5 shows the results of BLAST comparison of the ITS (internal transcribed spacer) portion (ITS1, 5.8S rRNA, and ITS2 base sequences) of S. cerevisiae S288C and S. cerevisiae KCCM12638, the parent strain of the mutant yeast of the present invention. Here, the query is the ITS portion (ITS1, 5.8S rRNA, ITS2) of S. cerevisiae S288C, and the subject is the ITS portion (ITS1, 5.8S rRNA, ITS2) of S. cerevisiae KCCM12638. The query sequence is shown in SEQ ID NO: 1, and the subject sequence is shown in SEQ ID NO: 2.
[0043] Figure 6 shows the results of BLAST comparison of the ITS portion (ITS1, 5.8S rRNA and ITS2 base sequences) of the parent strain Saccharomyces cerevisiae KCCM12638 and the Saccharomyces cerevisiae mutant strain HS-Y010 (accession number KCTC 15341BP) derived therefrom. At this time, the query is the ITS portion (ITS1, 5.8S rRNA, ITS2) of Saccharomyces cerevisiae KCCM12638, and the subject is the ITS portion (ITS1, 5.8S rRNA, ITS2) of Saccharomyces cerevisiae HS-Y010 (accession number KCTC 15341BP). The query sequence is shown in SEQ ID NO: 2, and the subject sequence is shown in SEQ ID NO: 3.
[0044] Hereinafter, the present invention will be described in more detail.
[0045] All technical terms used in this invention, unless otherwise defined, have the same meaning as commonly understood by those skilled in the art. While preferred methods and samples are described herein, similar or equivalent methods are also included within the scope of the present invention.
[0046] All numbers expressing sizes, quantities, and physical properties of features used in this specification and claims are to be understood as being modified in all instances by the term "about." Accordingly, unless indicated to the contrary, the numerical parameters set forth in this specification and claims are approximations that may vary depending on the desired properties sought to be obtained by those skilled in the art utilizing the teachings disclosed herein.
[0047] The present inventors, in response to the need for development of a technology capable of improving the heme productivity of yeast in a simpler manner using wild-type yeast, selected a wild-type yeast strain with high heme productivity among various yeast strains already used in the food industry as a parent strain, and produced a mutant strain with improved heme productivity compared to the wild-type strain by irradiating the parent strain with ultraviolet rays under specific conditions.
[0048] Accordingly, the first aspect of the present invention relates to a Saccharomyces cerevisiae mutant strain HS-Y010 (accession number KCTC 15341BP) having improved heme production ability compared to the wild type and a method for producing the same.
[0049] In a specific embodiment of the present invention, in order to produce a high-heme content yeast strain that can be directly applied to the food industry, a high-heme content yeast strain was first selected from among various yeast strains already used in the food industry and utilized as a parent strain. As a result of the selection, it was confirmed that S. cerevisiae KCCM12638, a type of wild-type Saccharomyces cerevisiae, had a higher heme production ability than other yeast strains, and this was selected as the parent strain.
[0050] In another specific embodiment of the present invention, in order to optimize the culture conditions of Saccharomyces cerevisiae KCCM12638 selected as the parent strain, the parent strain was inoculated in 40YP20D medium containing glucose as a carbon source, yeast extract and bacto peptone as nitrogen sources, and fed-batch culture was performed by controlling the acidity, stirring speed and air injection speed of the culture medium. As a result, as shown in FIGS. 2 and 3, it was confirmed that the parent strain exhibited the highest heme productivity when fed-batch culture was performed at pH 3 to 6, stirring speed of 100 to 1500 rpm, and air injection speed of 0.5 to 10 vvm.
[0051] At this time, the glucose contained in the medium may be replaced with other substances commonly used as carbon sources, such as fructose or galactose, but is not limited thereto. In addition, as a nitrogen source contained in the medium, yeast extract may be used at 2 to 6% (w / v) and peptone may be used at 0.1 to 3% (w / v), but is not limited thereto. A person skilled in the art can appropriately select the types and concentrations of carbon and nitrogen sources contained in the medium according to the culture conditions.
[0052] In a specific embodiment of the present invention, a mutant yeast strain with improved heme productivity compared to the wild type was prepared by irradiating Saccharomyces cerevisiae KCCM12638 with UV light, which exhibits high heme productivity. To prepare the mutant yeast strain, a PCR tube containing the parent strain was placed at a distance of 30 cm under a 254 nm UV lamp for 2 to 12 hours. As a result, as shown in Fig. 4, it was confirmed that a 97.8% death rate was observed 2 hours after UV irradiation, and this time period was selected as the optimal UV irradiation time.
[0053] After UV treatment, colonies that grew were randomly selected and the heme concentration was analyzed. As a result, a mutant yeast strain with a heme content increased by approximately 25% compared to the parent strain was discovered. This was named Saccharomyces cerevisiae HS-Y010 and deposited in the Korea Center for Bioscience and Biotechnology (KCTC) Gene Bank on March 7, 2023, and was assigned the accession number KCTC 15341BP.
[0054] Therefore, the Saccharomyces cerevisiae mutant strain HS-Y010 (accession number KCTC 15341BP) having improved heme production ability compared to the wild type can be derived from Saccharomyces cerevisiae KCCM12638, and Saccharomyces cerevisiae KCCM12638 was irradiated with ultraviolet rays having a wavelength of 250 to 260 nm at a distance of 20 to 50 cm in the vertical direction at a dose of 3000 to 9000 mW / cm. 2 It can be manufactured by irradiating for 1 to 2 hours with an amount of .
[0055] At this time, if the distance to which ultraviolet rays are irradiated is less than 20 cm in the vertical direction, a problem may arise in which the mortality rate significantly increases even with short-term ultraviolet irradiation, and if the distance to which ultraviolet rays are irradiated is more than 50 cm in the vertical direction, a problem may arise in which mutations are not induced even with long-term ultraviolet irradiation.
[0056] At this time, if the UV irradiation time is less than 1 hour, the mortality rate is low, making it difficult to select strains with induced mutations. Since the mortality rate changes little over time after 2 hours of UV irradiation, irradiation for longer than 2 hours is unnecessary.
[0057] The present inventors attempted to identify the distribution and pattern of mutations at the genome level in the Saccharomyces cerevisiae mutant strain HS-Y010 (accession number KCTC 15341BP) with improved heme production compared to the wild type through whole genome re-sequencing. To this end, first, using Saccharomyces cerevisiae S288C as the whole genome, single nucleotide polymorphism (SNP) information was obtained between the parent strain KCCM12638 and the UV mutant strain HS-Y010 (accession number KCTC 15341BP), and the ITS1, 5.8S rRNA, and ITS2 sequences (hereinafter referred to as “ITS portions”) were extracted from the base sequences obtained through whole genome resequencing, and BLAST was performed to compare the ITS portions of the UV mutant strain HS-Y010 (accession number KCTC 15341BP) and the parent strain KCCM12638. As a result, as shown in Fig. 5, 841 base sequences out of 848 KCCM12638 ITS portions matched S288C, and as shown in Fig. 6, 848 out of 848 base sequences matched between the ITS portions of KCCM12638 and UV mutant strain HS-Y010 (accession number KCTC 15341BP), confirming that UV mutant strain HS-Y010 is also a Saccharomyces cerevisiae strain derived from KCCM12638.
[0058] Next, to confirm whether the UV mutant strain HS-Y010 (accession number KCTC 15341BP) was an independently produced strain modified from KCCM12638, the SNPs of KCCM12638 and HS-Y010 (accession number KCTC 15341BP) were compared. As a result, as shown in Table 4, HS-Y010 (accession number KCTC 15341BP) had at least 12 SNPs compared to the KCCM12638 strain, namely, the 2383T>A mutation on chromosome 1, the 1783G>A mutation on chromosome 2, the 570166G>T mutation on chromosome 5, the 8579T>C, 158964T>A mutations on chromosome 7, the 364680A>T, 526390T>A mutations on chromosome 8, the 1064817G>T mutation on chromosome 12, the 908390C>T mutation on chromosome 13, the 783791C>T, 783810G>T mutation on chromosome 14, and the 30149A>T mutation on chromosome 15. It has been confirmed.
[0059] The Saccharomyces cerevisiae mutant strain HS-Y010 (accession number KCTC 15341BP) manufactured in this manner exhibits improved heme production ability compared to the wild-type Saccharomyces cerevisiae KCCM12638, which is the parent strain, and thus can be used in a method for mass-producing heme industrially.
[0060] Accordingly, the second aspect of the present invention relates to a method for producing heme using the above-described Saccharomyces cerevisiae mutant strain HS-Y010 (accession number KCTC 15341BP) and a medium composition for culturing the strain.
[0061] Specifically, the method for producing heme may include a) a step of culturing a Saccharomyces cerevisiae mutant strain HS-Y010 (accession number KCTC 15341BP); and b) a step of recovering heme from the strain.
[0062] In the present invention, the culture in step a) may be performed using the pre-culture solution in which the strain is cultured, using an isolated strain, or using a strain or culture thereof stored frozen.
[0063] In the present invention, the term "cultivation" means growing the strain under appropriately artificially controlled environmental conditions. The culturing method according to the present invention includes batch culture, continuous culture, and fed-batch culture, and specifically, continuous culture can be performed in a batch process or a fed batch or repeated fed batch process, but is not limited thereto.
[0064] The cultivation according to the present invention is not particularly limited, but can be conducted using, for example, a liquid culture tank, a rotary drum fermentor, or a tray fermentor. In addition to the rotary drum or tray fermentor, any device useful for fermenting strains can be used in the method of the present invention without limitation in its form, and an appropriate device can be selected and used depending on the production scale.
[0065] In the present invention, the pH of the culture can be adjusted by appropriately adding compounds such as ammonium hydroxide, potassium hydroxide, ammonia, phosphoric acid, and sulfuric acid to the culture during cultivation. During cultivation, foaming can be suppressed by using an antifoaming agent such as a fatty acid polyglycol ester. Furthermore, oxygen or an oxygen-containing gas can be injected into the culture to maintain an aerobic state.
[0066] According to a specific embodiment of the present invention, the Saccharomyces cerevisiae mutant strain HS-Y010 (accession number KCTC 15341BP) of step a) can be cultured in the same medium as the medium for cultivating its parent strain, Saccharomyces cerevisiae KCCM12638.
[0067] For example, the strain of step a) above can be cultured in a medium containing at least one selected from the group consisting of glucose, fructose or galactose as a carbon source, and yeast extract, peptone, tryptone, malt extract, beef extract, casein, soytone, sodium nitrate (NaNO3), ammonium chloride (NH4Cl) and ammonium sulphate ((NH4)2SO4) as a nitrogen source. Specifically, the strain of step a) can be cultured in a medium containing 3 to 7% (w / v) of glucose, fructose or galactose as a carbon source, 2 to 6% (w / v) of yeast extract as a nitrogen source and 0.1 to 3% (w / v) of peptone, but is not limited thereto, and a person skilled in the art can appropriately select the types and concentrations of carbon sources and nitrogen sources included in the medium according to culture conditions for the purpose of increasing heme productivity.
[0068] In addition, the culture conditions of the Saccharomyces cerevisiae mutant strain HS-Y010 (accession number KCTC 15341BP) of step a) above can be cultured under the same conditions as the culture conditions of its parent strain, Saccharomyces cerevisiae KCCM12638.
[0069] For example, the strain of step a) above can be fed-batch cultured at a pH of 3 to 6, more preferably at a pH of 3 or more and less than 5.5, at a stirring speed of 100 to 1500 rpm, and with air injected at a speed of 0.5 to 10 vvm, but is not limited thereto, and a person skilled in the art can appropriately adjust the pH, stirring speed, air injection speed, etc. for the purpose of increasing heme productivity.
[0070] At this time, an additional supply solution may be injected at the point where all of the initial glucose has been consumed in step a). The supply solution may contain various carbon sources and / or various nitrogen sources, similar to the initial medium, and may contain the same or different carbon sources and / or nitrogen sources as the initial medium. In a specific embodiment of the present invention, a supply solution containing the same carbon source and nitrogen source as the initial medium but at a high concentration is injected. However, a person skilled in the art can appropriately select and adjust the components and concentrations thereof included in the supply solution in consideration of the components and culture conditions of the initial medium.
[0071] The injection rate of the above-mentioned supply solution can be determined within a range where the glucose concentration of the culture medium is close to 0 g / L and the ethanol concentration does not exceed 10 g / L. The injection rate of the supply solution including a carbon source and a nitrogen source within the above range may be, for example, 1 to 50 mL / hr, preferably 2 to 35 mL / hr, but is not limited thereto.
[0072] In the heme production method of the present invention, step b) can be performed using a method known in the art for recovering heme by crushing a yeast strain.
[0073] According to a specific embodiment of the present invention, step b) can be performed by a series of processes described in FIG. 1.
[0074] The process of the above drawing 1 is briefly described as follows.
[0075] First, the yeast strain that went through the culture process of step a) above was centrifuged and then OD 600 *mL=0.4 ml of yeast lysis buffer per 60 (e.g. Y-PER 쪠 Add Yeast Protein Extraction Reagent (YEPR) to disrupt the yeast cells, add 1.2 ml of acetonitrile (ACN) to 0.4 ml of the disrupted yeast extract, react for 5 minutes, centrifuge, remove the supernatant, and collect only the precipitate. Add 1.6 ml of an acetonitrile: 1.7 M hydrochloric acid (HCl) solution prepared by mixing in a volume ratio of 8:2 to the recovered precipitate, react for 20 minutes, and additionally add 0.4 ml of a solution containing saturated concentrations of MgSO4 and 100 μg / L of NaCl at room temperature, stir for 5 minutes, centrifuge to separate the aqueous layer and the acetonitrile layer, and recover the acetonitrile layer containing heme.
[0076] In the present invention, methods for recovering heme may include, but are not limited to, centrifugation, filtration, anion exchange chromatography, crystallization, and HPLC.
[0077] In the heme production method of the present invention, step b) can harvest the strain to recover heme before the heme concentration in the medium reaches 0.5 mM. This is because when the heme concentration in the medium reaches 0.5 mM, yeast growth may be inhibited, thereby reducing heme production.
[0078] In the present invention, step b) may include additionally recovering heme from the strain culture solution.
[0079] In the heme production method of the present invention, the culture medium used in step a) may be optimized to increase the heme productivity of the Saccharomyces cerevisiae mutant strain HS-Y010 (accession number KCTC 15341BP).
[0080] Accordingly, the second aspect of the present invention provides a medium composition for culturing a mutant strain HS-Y010 of Saccharomyces cerevisiae (accession number KCTC 15341BP).
[0081] The medium composition according to the present invention may include the medium used in step a) of the above-described heme production method, and includes, for example, but is not limited to, i) 3 to 7% (w / v) of glucose, fructose or galactose as a carbon source; and ii) 2 to 6% (w / v) of yeast extract and 0.1 to 3% (w / v) of peptone as a nitrogen source.
[0082] In the present invention, when the medium composition is used, the mutant strain HS-Y010 (accession number KCTC 15341BP) of Saccharomyces cerevisiae exhibits improved heme productivity compared to its parent strain, Saccharomyces cerevisiae KCCM12638, and thus the medium composition can be used as a medium composition for heme production.
[0083] Accordingly, a second aspect of the present invention provides the use of the aforementioned composition for enhancing heme production of Saccharomyces cerevisiae mutant strain HS-Y010 (Accession No. KCTC 15341BP), wherein the composition may comprise i) 3 to 7% (w / v) of glucose, fructose or galactose as a carbon source; and ii) 2 to 6% (w / v) yeast extract and 0.1 to 3% (w / v) peptone as a nitrogen source.
[0084] Furthermore, a second aspect of the present invention provides the use of the aforementioned composition for the preparation of a culture medium for enhancing heme production of Saccharomyces cerevisiae mutant strain HS-Y010 (accession number KCTC 15341BP), wherein the composition may comprise i) 3 to 7% (w / v) of glucose, fructose or galactose as a carbon source; and ii) 2 to 6% (w / v) of yeast extract and 0.1 to 3% (w / v) of peptone as a nitrogen source.
[0085] Heme produced as described above can be used in various foods.
[0086] Accordingly, the third aspect of the present invention relates to a food composition comprising a mutant strain HS-Y010 of Saccharomyces cerevisiae (accession number KCTC 15341BP), a culture of the strain, heme produced from the strain, or heme isolated from a culture of the strain.
[0087] In the present invention, the strain may be at least one selected from the group consisting of the strain itself, a strain lysate, a strain concentrate, a strain extract, and a strain dried product.
[0088] In the present invention, the term "disintegrant" may be obtained by physically and chemically treating the strain itself, by high-pressure sterilization or ultrasonic treatment, or by disintegrating the supernatant, fermentation product or culture solution obtained by centrifuging the culture of the strain, but is not limited thereto.
[0089] The term "fermented product" of the present invention may include a medium containing a strain, its metabolites, and extra nutrients obtained by culturing a microorganism in a medium for a certain period of time, a culture solution from which the strain has been removed, a dilution or concentrate of the medium or culture solution, or a dried product thereof. The term "fermentation" refers to a process in which a microorganism uses its own enzymes to decompose organic matter, other than a putrefaction reaction.
[0090] In the present invention, the method for obtaining a fermented product from the strain is not particularly limited, and the fermented product can be obtained according to a method commonly used in the relevant technical field or a similar field.
[0091] In the present invention, the fermentation product obtained from the strain may include not only the fermented material itself, but also a culture medium of the strain in which the strain and the culture coexist, a fermentation product obtained by filtering the strain from the culture medium, a supernatant obtained by centrifuging the culture medium to remove the strain, a fermentation product obtained by sterilizing the strain from the culture medium and filtering it, an extract obtained by extracting the fermentation product or the culture medium containing it, a diluted solution obtained by diluting the fermentation product or its extract, a dried product obtained by drying the fermentation product or its extract, a lysate obtained by capturing and crushing the cells of the strain, and all kinds of materials including the fermentation product generated from the strain.
[0092] In the present invention, the term "extract" refers to the resultant product, such as a liquid component obtained by immersing a target substance in various solvents and then extracting it for a certain period of time at room temperature, low temperature, or heated conditions, or a solid component obtained by removing the solvent from the liquid component. In addition, it can be comprehensively interpreted to include, in addition to the resultant product, a dilution of the resultant product, a concentrate thereof, a controlled product thereof, a purified product thereof, etc.
[0093] In the present invention, the term "dry product" refers to a strain or culture from which moisture has been removed, and may include a fungus and culture dried by a known drying method such as spray drying, freeze drying, or vacuum drying.
[0094] In the present invention, the term "culture" refers to a product obtained by culturing the strain in a medium. For example, the culture of the present invention may include a component remaining in the medium remaining after harvesting the strain from the culture medium of Saccharomyces cerevisiae mutant strain HS-Y010 (Accession No. KCTC 15341BP), or may include a component of a culture medium containing the strain. The term "culture solution" in the present invention refers to a portion of the culture excluding the strain. For example, the culture solution of the present invention may include a portion of the culture supernatant excluding the strain or a culture supernatant excluding the lysate after centrifugation from the culture medium of Saccharomyces cerevisiae mutant strain HS-Y010 (Accession No. KCTC 15341BP).
[0095] The culture may be a Saccharomyces cerevisiae mutant strain HS-Y010 (accession number KCTC 15341BP), a whole culture of the strain, a culture medium, fractions thereof, etc. The culture solution may be a culture supernatant of the strain, etc. In this case, the culture supernatant may be obtained by centrifuging a culture of the strain, and the fraction may be obtained by subjecting the strain, the culture, the culture supernatant, etc. to a method such as centrifugation or chromatography.
[0096] In the present invention, the food composition may contain 0.02 to 80 wt%, preferably 0.02 to 50 wt%, of the strain, a culture of the strain, heme produced from the strain, or heme isolated from the culture of the strain, based on the total weight of the composition, but is not limited thereto, and the content thereof may be appropriately changed depending on the type of food, the food consumption target, the consumption purpose, etc.
[0097] In the present invention, the food may be, but is not limited to, artificial meat or a meat substitute. In the present invention, the artificial meat or meat substitute refers to a meat imitation that has a texture, flavor, and / or aroma similar to that of meat.
[0098] The food composition is not particularly limited as long as it is a drinkable food. Non-limiting examples of the food include hot dogs, burgers, mincemeat, sausages, steaks, fillets, grilled meats, breasts, thighs, wings, meatballs, meatloaf, bacon, strips, fingers, nuggets, cutlets, or cubes of animal-based or non-animal-based (e.g., plant-based) food products, or a combination of animal-based or non-animal-based food products.
[0099] The food may in another embodiment be provided in the form of a soup or stew base, a bouillon, for example, as a powder or cube, a flavor packet, or a food additive such as a seasoning packet or shaker.
[0100] Hereinafter, the present invention will be described in more detail through examples. However, the present invention can be modified in various ways and can take various forms. Therefore, the specific examples and descriptions described below are only intended to aid in understanding the present invention and are not intended to limit the present invention to a specific disclosed form. It should be understood that the scope of the present invention includes all modifications, equivalents, and substitutes included in the spirit and technical scope of the present invention.
[0101] [Example 1]
[0102] Selection and analysis of yeast parent strains
[0103] 1-1. Selection of parent strain
[0104] To produce a high-heme yeast strain that can be directly applied to the food industry, Saccharomyces cerevisiae KCCM12638, a wild-type Saccharomyces cerevisiae strain used in whiskey production, was obtained from the Korea Microbiological Conservation Center. To determine the culture performance and heme content of the parent strain, the following steps 1-2 to 1-5 were performed.
[0105] 1-2. Pre-culture
[0106] Fifty μl of yeast glycerol stock stored in a deep freezer was inoculated into test tubes containing 5 mL YP20D (1% (w / v) yeast extract (10 g / L), 2% (w / v) bacto peptone (20 g / L), 2% (w / v) glucose (20 g / L)) medium and pre-cultured at 25°C and 250 rpm for 48 h.
[0107] 1-3. Main culture and yeast cell disruption
[0108] The pre-cultured yeast strain was inoculated into a baffled flask containing 100 mL of YP50D (1% (w / v) yeast extract (10 g / L), 2% (w / v) bacto peptone (20 g / L), 5% (w / v) glucose (50 g / L)) medium so that the optical density at 600 nm (OD600) became 1.0. The yeast strain cells were cultured with shaking at 25°C and 250 rpm for 48 hours, and centrifuged to recover OD600ХmL=60 (for example, if OD600=1, 60 mL of culture medium). Then, 0.4 mL of Y-PER™ Yeast Protein Extraction Reagent (Thermo Fisher Scientific Inc., Rockford, IL, USA) was added to disrupt the yeast cells.
[0109] 1-4. Measuring heme concentration
[0110] As shown in Fig. 1, yeast cell disruption solution was pretreated to measure the heme concentration present in the yeast extract. Following the procedure in Fig. 1, 1.2 ml of acetonitrile (ACN) was added to 0.4 ml of yeast extract, reacted for 5 minutes, centrifuged, and the supernatant was removed, and only the precipitate was collected. 1.6 ml of an acetonitrile: 1.7 M hydrochloric acid (HCl) solution prepared by mixing 8:2 by volume was added to the recovered precipitate, and reacted for 20 minutes. Additionally, 0.4 ml of a solution containing saturated concentrations of MgSO4 and 100 μg / L NaCl at room temperature was added, stirred for 5 minutes, and centrifuged to separate the aqueous layer and the acetonitrile layer. The acetonitrile layer containing heme was collected and then analyzed by HPLC.
[0111] The concentration of heme was measured by high-performance liquid chromatography (HPLC) (Thermo fisher Ultimate 3000) equipped with a YMC-Pack ODS-A, 12 nm, 5 μm, 150 × 4.6 mm column (YMC, Japan) and a UV detector. Detailed analysis conditions are shown in Tables 1 and 2. Hemin (Sigma, USA) was used as a heme standard.
[0112] HPLC conditionsMobile phase AACN / H2O (5:95 v / v) + 0.1% Formic acidMobile phase BACN / H2O (95:5 v / v) + 0.1% Formic acidFlow rate0.4 mL / minInjection volume20 μLAutosampler temperature5 ℃Colum temperature50 ℃DetectorUV-Vis at 400 nm
[0113] GradientTime [min]A (%)B (%)0802010010011010011.10100128020258020
[0114] The heme concentration of Saccharomyces cerevisiae D452-2, a general laboratory yeast strain, was compared with that of Saccharomyces cerevisiae KCCM12638, a yeast strain for American whiskey production, as a control. Saccharomyces cerevisiae D452-2 produced 2.5 mg / L of heme, whereas Saccharomyces cerevisiae KCCM12638 produced 8.6 mg / L, showing a higher heme production than other yeast strains. Based on the results of this example, Saccharomyces cerevisiae KCCM12638 was used as a parent strain for UV random mutagenesis.
[0115] 1-5. Fed-batch cultivation of yeast and heme production concentration
[0116] Unlike batch culture, fed-batch culture can significantly increase cell mass by continuously supplying carbon and nitrogen sources necessary for microbial growth, thereby increasing the production of desired substances. In the present invention, the heme production of Saccharomyces cerevisiae KCCM12638 strain was ultimately increased through fed-batch culture.
[0117] Fed-batch culture was performed in a 2.5 L bioreactor with a working volume of 1 L. Pre-culture was performed in the same manner as in Example 1-2. The pre-cultured yeast strain was inoculated into a baffled flask containing 100 mL of YP20D medium so that the optical density at 600 nm (OD600) became 1.0, and sub-culture was performed at 25°C and 250 rpm for 48 hours. The subcultured yeast strain was inoculated into 1 L of 40YP20D ((4% (w / v) yeast extract (40 g / L), 2% (w / v) bacto peptone (20 g / L), 2% (w / v) glucose (20 g / L)) medium so that the optical density at 600 nm (OD600) became 1.0. The culture conditions were maintained at pH 3.5 or 4.5 and performed at 25 ℃, 700 rpm, 2 vvm. When the initial glucose was completely consumed, additional feeding solution (280 g / L yeast extract, 140 g / L bacto peptone, 350 g / L glucose) was injected at a flow rate of 4-24 mL / hr. The injection rate of the feeding solution was such that the glucose concentration of the yeast culture was close to 0 g / L and the ethanol concentration did not exceed 10 g / L. The dissolved oxygen (DO) was determined within the range of 0.01 to 0.01. The stirring speed and air injection rate were increased from a minimum of 700 rpm and 2 vvm to a maximum of 1200 rpm and 5 vvm, respectively, to maintain a high dissolved oxygen (DO) level. The concentrations of glucose, glycerol, acetate, and ethyl alcohol in the medium were measured by high performance liquid chromatography (HPLC) (Thermo fisher Ultimate 3000) equipped with a Rezex ROA-organic acid H+ column (Phenomenex, Torrance, CA) and a refractive index (RI) detector.The column temperature was maintained at 70°C, and a 5 mM sulfuric acid (H2SO4) solution was flowed as the mobile phase at a flow rate of 0.6 mL / min for detection. The heme concentration was measured using the method described in Example 1-4.
[0118] As a result of performing fed-batch culture using the above method under pH 3.5 and pH 4.5 conditions, as confirmed in Fig. 2, a maximum of 37.3 mg / L heme was produced under pH 3.5 conditions, and as confirmed in Fig. 3, a maximum of 48.5 mg / L heme was produced under pH 4.5 conditions, confirming that pH 4.5 conditions are desirable for heme production.
[0119] [Example 2]
[0120] Production of improved strains through random mutation
[0121] 2-1. UV random mutation production
[0122] Fifty μl of glycerol stock of yeast strain KCCM12638 stored in a deep freezer was inoculated into a test tube containing 5 mL YP20D (1% (w / v) yeast extract (10 g / L), 2% (w / v) bacto peptone (20 g / L), 2% (w / v) glucose (20 g / L)) medium and pre-cultured at 25°C and 250 rpm for 48 h.
[0123] The pre-cultured yeast strain was diluted to an optical density at 600 nm (OD600) of 1.0, and 0.2 mL was collected by centrifugation. The collected cells were dissolved in YP20D and transferred to a PCR tube. For UV random mutagenesis, the cells were placed under a 254 nm UV lamp at a distance of 30 cm and irradiated with 3,000 to 9,000 mW / cm 2PCR tubes containing yeast cells were placed in a UV irradiation chamber for 2 to 12 hours. As shown in Fig. 4, a 97.8% death rate was observed 2 hours after UV irradiation, and this time period was selected as the optimal UV irradiation time. Yeast cells irradiated for 2 hours were 10 3 , 10 4 , 10 5 After diluting by double, 0.1 mL was taken and spread on YPD agar medium and cultured at 30°C for 48 hours.
[0124] 2-2. Checking the heme content of the mutant strain
[0125] Colonies that emerged after UV treatment were randomly selected and subjected to pre-culture and main culture (baffle flask shaking culture) as in Example 1, and the heme concentration was analyzed. Among the analyzed colonies, strains with higher heme content than the parent strain KCCM12638 were selected. The culture performance (OD600) and heme content according to the results are shown in Table 3 below.
[0126] Strain 48 hours OD600 heme (mg / L) KCCM1263822.83.78 KCTC 15341BP (HS-Y010) 25.144.75
[0127] As can be seen from the results in Table 3 above, the OD600 of the tested strain was approximately 11% higher than that of the parent strain, KCCM12638, and the heme content also increased by 26%. The strain with an approximately 1.26-fold increase in heme content was named Saccharomyces cerevisiae HS-Y010, and this strain was deposited in the Korea Research Institute of Bioscience and Biotechnology, Bioresource Center, Gene Bank (KCTC) on March 7, 2023, and was assigned the accession number KCTC 15341BP.
[0128] [Example 3]
[0129] Identification and SNP analysis of UV mutant strains
[0130] We commissioned whole genome resequencing (WGRE) to Macrogen, and used Saccharomyces cerevisiae S288C as the whole genome to obtain SNP information between the parent strain KCCM12638 and the UV mutant strain HS-Y010 (accession number KCTC 15341BP). WGRE is a method of analyzing mutations between specific individuals in a species with a whole genome (reference genome) and comparing the base sequences of individuals or populations. WGRE can be used to identify the distribution and pattern of mutations at the genome level.
[0131] First, ITS1, 5.8S rRNA, and ITS2 sequences (hereinafter, ITS portion) were extracted from the base sequences obtained through whole genome resequencing to confirm whether HS-Y010 (accession number KCTC 15341BP) is the same Saccharomyces cerevisiae as the parent strain KCCM12638.
[0132] To compare the ITS region, BLAST (https: / blast.ncbi.nlm.nih.gov / ) was performed to compare the S288C of the whole genome from the whole genome resequencing with the ITS region of Saccharomyces cerevisiae KCCM12638, the parent strain of the mutant. As confirmed in the comparison results in Fig. 5, 841 of the 848 KCCM12638 ITS regions were identical to S288C.
[0133] Next, the ITS portions of the parent strain Saccharomyces cerevisiae KCCM12638 and the UV mutant strain Saccharomyces cerevisiae HS-Y010 (accession number KCTC 15341BP) were compared. As shown in Fig. 6, the ITS portions of S. cerevisiae KCCM12638 strain and S. cerevisiae HS-Y010 (accession number KCTC 15341BP) were identical at 848 base sequences, confirming that S. cerevisiae HS-Y010 (accession number KCTC 15341BP) was also a S. cerevisiae strain derived from KCCM12638.
[0134] Next, to confirm whether Saccharomyces cerevisiae HS-Y010 (accession number KCTC 15341BP) is an independently produced strain modified from KCCM12638, SNPs from the whole genome resequencing analysis were used. The results of comparing the SNPs of KCCM12638 and Saccharomyces cerevisiae HS-Y010 (accession number KCTC 15341BP) based on the chromosome sequence of S288C are shown in Table 4. The chromosome sequence information of S288C, which is the reference, is published in NCBI, and the NCBI ID information for each chromosome in Table 4 is shown in Table 5.
[0135] Chromosome locationS288CKCCM12638KCTC 15341BP(HS-Y010)12,383CTA21,783TGA5570,166AGT78,579ATC7158,964CTA8364,680C AT8526,390CTA121,064,817AGT13908,390GCT14783,791GCT14783,810AGT1530,149GAT
[0136] ChromosomeGenbank IDRefSeq ID1BK006935.2NC_001133.92BK006936.2NC_001134.85BK006939.2NC_001137.37BK006941.2NC_001139.98BK006934.2N C_001140.612BK006945.2NC_001144.513BK006946.2NC_001145.314BK006947.3NC_001146.815BK006948.2NC_001147.6
[0137] As shown in Table 4, Saccharomyces cerevisiae HS-Y010 (accession number KCTC 15341BP) has at least 12 SNPs compared to strain KCCM12638. Specifically, S. cerevisiae HS-Y010 (accession number KCTC 15341BP) has the following SNPs: 2383T>A mutation on chromosome 1, 1783G>A mutation on chromosome 2, 570166G>T mutation on chromosome 5, 8579T>C, 158964T>A mutation on chromosome 7, 364680A>T, 526390T>A mutation on chromosome 8, 1064817G>T mutation on chromosome 12, 908390C>T mutation on chromosome 13, 783791C>T, 783810G>T mutation on chromosome 14, and 30149A>T mutation on chromosome 15.
[0138] While specific aspects of the present invention have been described in detail above, it will be apparent to those skilled in the art that these specific descriptions merely represent preferred embodiments and are not intended to limit the scope of the present invention. Therefore, the substantial scope of the present invention is defined by the appended claims and their equivalents.
[0139] [Accession number]
[0140] Name of depositor: Korea Research Institute of Bioscience and Biotechnology, Biological Resource Center (KCTC)
[0141] Accession number: KCTC15341BP
[0142] Date of acceptance: 20230307
[0143]
Claims
1. Saccharomyces cerevisiae mutant strain HS-Y010 (accession number KCTC 15341BP) with increased heme production compared to the wild type.
2. In the first paragraph, the mutant strain HS-Y010 is a strain derived from Saccharomyces cerevisiae KCCM12638.
3. In the first paragraph, the mutant strain HS-Y010 is irradiated with ultraviolet rays of 250 to 260 nm wavelength at a vertical distance of 20 to 50 cm at a wavelength of 3000 to 9000 mW / cm to Saccharomyces cerevisiae KCCM12638. 2 A strain manufactured by irradiating with a quantity of 1 to 2 hours.
4. In the first paragraph, the mutant strain HS-Y010, compared to Saccharomyces cerevisiae KCCM12638, has a 2383T>A mutation in chromosome 1, a 1783G>A mutation in chromosome 2, a 570166G>T mutation in chromosome 5, a 8579T>C, 158964T>A mutation in chromosome 7, a 364680A>T, 526390T>A mutation in chromosome 8, a 1064817G>T mutation in chromosome 12, a 908390C>T mutation in chromosome 13, a 783791C>T, 783810G>T mutation in chromosome 14, and a 30149A>T mutation in chromosome 15. A strain having a single nucleotide sequence mutation. 5.a) Step of pre-cultivating Saccharomyces cerevisiae KCCM12638; and b) A step of irradiating the above-mentioned pre-cultured Saccharomyces cerevisiae KCCM12638 with ultraviolet rays; A method for producing a Saccharomyces cerevisiae mutant strain HS-Y010 (accession number KCTC 15341BP) having increased heme production ability compared to the wild type.
6. A manufacturing method in claim 5, further comprising, between steps a) and b), a step a') of diluting the pre-cultured strain so that the optical density at 600 nm becomes 0.5 to 1.
5.
7. In the 5th paragraph, step b) irradiates Saccharomyces cerevisiae KCCM12638 with ultraviolet rays having a wavelength of 250 to 260 nm at a distance of 20 to 50 cm in the vertical direction at a dose of 3000 to 9000 mW / cm 2 A manufacturing method that is performed by irradiating for 1 to 2 hours with an amount of .
8. A manufacturing method according to claim 5, further comprising, after step b), a step c) of selecting a mutant strain having a single nucleotide sequence mutation of 2383T>A mutation in chromosome 1, 1783G>A mutation in chromosome 2, 570166G>T mutation in chromosome 5, 8579T>C, 158964T>A mutation in chromosome 7, 364680A>T, 526390T>A mutation in chromosome 8, 1064817G>T mutation in chromosome 12, 908390C>T mutation in chromosome 13, 783791C>T, 783810G>T mutation in chromosome 14, and 30149A>T mutation in chromosome 15, compared to Saccharomyces cerevisiae KCCM12638.
9. Heme production method using Saccharomyces cerevisiae mutant strain HS-Y010 (accession number KCTC 15341BP) of paragraph 1.
10. In paragraph 9, a) a step of culturing Saccharomyces cerevisiae mutant strain HS-Y010 (accession number KCTC 15341BP); and b) a step of recovering heme from the strain; A method for producing heme, comprising:
11. A method for producing heme in claim 10, wherein the strain of step a) is cultured in a medium containing at least one selected from the group consisting of glucose, fructose or galactose as a carbon source, and yeast extract, peptone, tryptone, malt extract, beef extract, casein, soytone, sodium nitrate (NaNO3), ammonium chloride (NH4Cl) and ammonium sulfate (Ammonium sulphate, (NH4)2SO4) as a nitrogen source.
12. A method for producing heme in claim 11, wherein the nitrogen source is 2 to 6% (w / v) of yeast extract and 0.1 to 3% (w / v) of peptone.
13. A method for producing heme in claim 10, wherein the strain of step a) is cultured in a fed-batch manner at a pH of 3 to 6, at a stirring speed of 100 to 1500 rpm, and with air injected at a speed of 0.5 to 10 vvm. 14.i) 3 to 7% (w / v) of glucose, fructose or galactose as a carbon source; and ii) 2 to 6% (w / v) yeast extract and 0.1 to 3% (w / v) peptone as nitrogen source; A medium composition for culturing Saccharomyces cerevisiae mutant strain HS-Y010 (accession number KCTC 15341BP), comprising:
15. A medium composition according to claim 14, wherein the medium composition is a medium composition for heme production.
16. A food composition comprising a Saccharomyces cerevisiae mutant strain HS-Y010 (accession number KCTC 15341BP) having increased heme production ability compared to the wild type, a culture of the strain, heme produced from the strain, or heme isolated from a culture of the strain.
17. A food composition according to claim 16, wherein the food is an artificial meat or meat substitute food.
18. Use of the medium composition of Article 14 for increasing heme production of Saccharomyces cerevisiae mutant strain HS-Y010 (Accession No. KCTC 15341BP).
Citation Information
Patent Citations
A mutant strain of Saccaromyces cerevisiae havingenhanced productivity of mannoprotein
KR100614217B1
S. cerevisiae 6M with improving organic selenium production rate
KR101231652B1
Methods for increasing hemoprotein production in fungal mutants
WO1999029874A1
Extracellular heme production method using metabolically engineered microorganism
WO2019117612A1
